                               SEQUENCE LISTING

<110> WATERS TECHNOLOGIES CORPORATION
 
<120> IMPROVED PERFORMANCE AND DYNAMIC RANGE FOR OLIGONUCLEOTIDE 
      BIOANALYSIS THROUGH REDUCTION OF NON-SPECIFIC BINDING

<130> W-4192-WO01

<140>
<141>

<150> 63/058,737
<151> 2020-07-30

<150> 62/962,487
<151> 2020-01-17

<160> 8     

<170> PatentIn version 3.5

<210> 1
<211> 21
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<220>
<221> source
<223> /note="Description of Combined DNA/RNA Molecule: Synthetic
      oligonucleotide"

<400> 1
auggaauacu cuugguuact t                                                 21


<210> 2
<211> 15
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 2
tttttttttt ttttt                                                        15


<210> 3
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 3
tttttttttt tttttttttt                                                   20


<210> 4
<211> 25
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 4
tttttttttt tttttttttt ttttt                                             25


<210> 5
<211> 30
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 5
tttttttttt tttttttttt tttttttttt                                        30


<210> 6
<211> 35
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 6
tttttttttt tttttttttt tttttttttt ttttt                                  35


<210> 7
<211> 40
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 7
tttttttttt tttttttttt tttttttttt tttttttttt                             40


<210> 8
<211> 25
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 8
ctctcgcacc catctctctc cttct                                             25


